NASDAQ: CHEK - Check-Cap Ltd.

半年間の収益性: -57.81%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Check-Cap Ltd.


会社について Check-Cap Ltd.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.

さらに詳しく
Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

IPO date 2015-02-19
ISIN IL0011336851
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.check-cap.com
Цена ао 0.87
1日あたりの価格変動: -4.56% (0.84)
週ごとの価格変動: +3.58% (0.774)
月ごとの料金変更: -19.02% (0.99)
3ヶ月間の価格変動: -0.4099% (0.805)
半年間の価格変動: -57.81% (1.9)
年間の価格変動: -61.08% (2.06)
3年間の価格推移: +36.58% (0.587)
5年間の価格推移: -57.13% (1.87)
10年間の価格推移: 0% (0.8017)
年初からの価格変動: +40.65% (0.57)

過小評価

名前 意味 学年
P/S 0 0
P/BV 0.5531 10
P/E 0 0
EV/EBITDA 0.6604 10
合計: 5

効率

名前 意味 学年
ROA, % -70.22 0
ROE, % -74.17 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.0546 10
合計: 9.6

成長の衝動

名前 意味 学年
収益性 Revenue, % -130.96 0
収益性 Ebitda, % 26.06 4
収益性 EPS, % -91.18 0
合計: 2.6



スーパーバイザー 役職 支払い 生年
Dr. Yoav Kimchy Ph.D. Founder, Head of R&D and Member of Scientific Advisory Board 362.65k 1961 (64 年)
Ms. Noa Reshef M.B.A. Head of Operations N/A
Mr. Saar Levi Interim Chief Executive Officer 1967 (58 年)
David Benaim Interim Chief Financial Officer

住所: Israel, Isfiya, Check-Cap Building - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.check-cap.com